Clinical Trial Update: Nilotinib Pre and Post Allogeneic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nilotinib given before and after allogeneic stem cell transplantation in chronic myeloid leukemia and acute lymphoblastic leukemia; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (Tasigna) (nilotinib)

Snippet

Sponsor: Sheba Medical Center | Conditions: Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED